We serve Chemical Name:(6-chloropyridazin-3-yl)-phenylmethanone CAS:146233-32-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(6-chloropyridazin-3-yl)-phenylmethanone
CAS.NO:146233-32-1
Synonyms:3-Benzoyl-6-chloropyridazine
Molecular Formula:C11H7ClN2O
Molecular Weight:218.63900
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:417.025ºC at 760 mmHg
Density:1.318g/cm3
Index of Refraction:1.605
PSA:42.85000
Exact Mass:218.02500
LogP:2.36100
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Benzoyl-6-chloropyridazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Benzoyl-6-chloropyridazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Benzoyl-6-chloropyridazine Use and application,3-Benzoyl-6-chloropyridazine technical grade,usp/ep/jp grade.
Related News: ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.�� (6-chloropyridazin-3-yl)-phenylmethanone manufacturer GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. (6-chloropyridazin-3-yl)-phenylmethanone supplier ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.�� (6-chloropyridazin-3-yl)-phenylmethanone vendor We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. (6-chloropyridazin-3-yl)-phenylmethanone factory We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.
